MSD Ireland marks €1bn invested in patient-focused innovation
Scientists at MSD Ireland are very proud to help contribute solutions and innovations towards important goals, including announcing a target date of 2040 for the elimination of cervical cancer.
Mairead McCaul, managing director, MSD Ireland Human Health and head of MSD Ireland country leadership team, reflects on why the team at MSD are delighted to make a positive contribution to global health
At MSD Ireland, we’re extremely proud to be one of the country’s leading and most innovative healthcare companies. Having first established in Ireland over 50 years ago, we are continuously growing our team and network of sites across the country in our pursuit to help improve the lives of people and patients across the world.
Over the last years, we have invested hugely in the Irish market, with over 3,100 people currently employed in our six sites across the country in Brinny, Co Cork, Ballydine, Co Tipperary, Dunboyne, Co Meath, Co Carlow, and Co Dublin. Our Irish sites play a vital role in our global operations, researching, innovating, and manufacturing medicines and vaccines from MSD Ireland to the world.
Last year, our business celebrated a €1 billion investment in our Irish operations and the creation of 650 new jobs, particularly focused on expansions for our MSD Carlow and MSD Dunboyne sites and the key role these cutting-edge, global biopharma hubs will play in helping to bring forward the future of pharma innovation.
MSD Dunboyne is MSD’s first single-use commercialisation facility, taking a highly innovative approach to pharmaceutical manufacturing, with state-of-the-art, single-use technology that provides a unique opportunity to work on a range of medicines to better adapt and respond to patient needs across the world.
Adding to the incredible capabilities of the MSD Dunboyne site and co-located next to the main facility, we recently opened the doors to a premier, cutting-edge, global-scale R&D centre: our new Biologics Innovation Acceleration facility. This research and advancement facility is a one-of-a-kind hub in Ireland and Europe, supporting an innovative new approach to developing and launching MSD’s future biologics medicines which will enable significant improvements in the time it takes to bring innovative new products to the patients who need them.
A first-of-its-kind centre in Ireland, this facility proves first-hand what the incredible talent and commitment of the Irish workforce across STEM and biopharma can achieve, making a significant difference for people and patients all over the world.
All across Ireland and at the heart of everything we do, is an unshakable commitment to making a difference — for our employees, for our communities and for the people across the world who rely on our products.
At MSD Ireland, we believe innovation can only be measured through the metrics of what it enables for people and patients. We’re at an exciting point where the successes of pharmaceutical innovation and new solutions are more tangible than ever before.
Cervical cancer is a clear example of this. In November of last year, Ireland joined other European countries in announcing a target date for the elimination of cervical cancer towards 2040. This represents a significant milestone in the global drive to eliminate cervical cancer, and one of the most tangible examples of what innovation in prevention and treatment can help achieve.
Being able to say Ireland will have eliminated a cancer within our lifetime — within the space of a couple of generations — is truly amazing. We are extremely proud to help contribute solutions and innovations towards such an important goal.
In Ireland, the most recent figures show that an estimated 350 cases of cervical cancer are diagnosed every year, with over 100 associated deaths annually. This 2040 milestone represents a future Ireland where no woman will endure the harrowing and worrying process that a cervical cancer diagnosis brings. This future is not only achievable but achievable in our lifetime, just 16 years from now, by 2040.
As we continue to grow our presence across the country, at MSD Ireland, we always remain committed to ensuring we’re making a difference through our work.
From our Irish operations, we’re proud to be pioneering the way towards innovative medicines and vaccines that can make a real impact in the lives of so many, here in Ireland and around the world, making every effort to connect the products with those who need them and moving towards a healthier future for all.
